11/12/2019  8:03:09 PM Chg. -1.44 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
89.43USD -1.58% 7,309
Turnover: 655,619.95
-Bid Size: - -Ask Size: - 3.99 bill.USD 0.00% 6.72

Business description

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening cardiovascular and infectious diseases and cancer.
 

Management board & Supervisory board

CEO
Dr. Martine A. Rothblatt
Management board
James C. Edgemond, Michael Benkowitz, Paul A. Mahon
Supervisory board
Dr. Martine A. Rothblatt, Christopher Causey, Christopher Patusky, Judy D. Olian, Katherine J. Klein, Louis Sullivan, Nilda Mesa, Prof. Raymond Dwek, Ray Kurzweil, Richard Giltner, Tommy G. Thompson
 

Company data

Name: United Therapeutics Corporation
Address: 1040 Spring Street,Silver Spring, Maryland 20910, USA
Phone: +1-301-608-9292
Fax: +1-301-608-9291
E-mail: -
Internet: is.gd/1hUSaA
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: 12/31
Free Float: 55.20%
IPO date: -

Investor relations

Name: -
IR phone: -
IR Fax: -
IR e-mail: ir@unither.com

Main Shareholders

Freefloat
 
55.20%
BlackRock, Inc
 
11.30%
The Vanguard Group
 
8.90%
Martine Rothblatt
 
7.30%
FMR, LLC
 
6.60%
AQR Capital Management, LLC
 
5.70%
Renaissance Technologies LLC
 
5.00%